DK652688A - Substituerede benzazepiner, deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne - Google Patents

Substituerede benzazepiner, deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne

Info

Publication number
DK652688A
DK652688A DK652688A DK652688A DK652688A DK 652688 A DK652688 A DK 652688A DK 652688 A DK652688 A DK 652688A DK 652688 A DK652688 A DK 652688A DK 652688 A DK652688 A DK 652688A
Authority
DK
Denmark
Prior art keywords
compounds
alkyl
pharmaceutical compositions
preparation
alkoxyalkyl
Prior art date
Application number
DK652688A
Other languages
English (en)
Other versions
DK165688C (da
DK165688B (da
DK652688D0 (da
Inventor
Joel Gilbert Berger
Wei Kong Chang
Marjorie Peters
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK652688A publication Critical patent/DK652688A/da
Publication of DK652688D0 publication Critical patent/DK652688D0/da
Publication of DK165688B publication Critical patent/DK165688B/da
Application granted granted Critical
Publication of DK165688C publication Critical patent/DK165688C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK652688A 1987-03-27 1988-11-23 5,7,8-trisubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner, farmaceutiske praeparater indeholdende forbindelserne og anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater til behandling af psykoser DK165688C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3213587A 1987-03-27 1987-03-27
US3213587 1987-03-27
US8800899 1988-03-24
PCT/US1988/000899 WO1988007526A1 (en) 1987-03-27 1988-03-24 Substituted benzazepines, their preparation and pharmaceutical compositions containing them

Publications (4)

Publication Number Publication Date
DK652688A true DK652688A (da) 1988-11-23
DK652688D0 DK652688D0 (da) 1988-11-23
DK165688B DK165688B (da) 1993-01-04
DK165688C DK165688C (da) 1993-05-24

Family

ID=21863286

Family Applications (1)

Application Number Title Priority Date Filing Date
DK652688A DK165688C (da) 1987-03-27 1988-11-23 5,7,8-trisubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner, farmaceutiske praeparater indeholdende forbindelserne og anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater til behandling af psykoser

Country Status (18)

Country Link
EP (2) EP0357641A1 (da)
JP (1) JPH0662574B2 (da)
KR (1) KR930011489B1 (da)
AT (1) ATE112766T1 (da)
AU (1) AU619744B2 (da)
CA (1) CA1321195C (da)
DE (1) DE3851769T2 (da)
DK (1) DK165688C (da)
FI (1) FI894566A7 (da)
HU (1) HU205744B (da)
IL (1) IL85855A (da)
MY (1) MY103357A (da)
NO (1) NO174507B (da)
NZ (1) NZ224038A (da)
PH (1) PH27337A (da)
PT (1) PT87068B (da)
WO (1) WO1988007526A1 (da)
ZA (1) ZA882080B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK107688D0 (da) * 1988-03-01 1988-03-01 Novo Industri As Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
ZA914536B (en) * 1990-06-15 1992-03-25 Schering Corp 8-lower alkyl-5-cycloalkyl or 5-cycloakenyl substituted benzazepines and pharmaceutical compositions containing them
EP0551312A1 (en) * 1990-09-25 1993-07-21 Schering Corporation Peri-condensed benzazepines
US5241065A (en) * 1992-02-25 1993-08-31 Schering Corporation 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
ES2250432T3 (es) * 2000-07-05 2006-04-16 Ortho-Mcneil Pharmaceutical, Inc. Espirobenzoazepinas no peptidicas sustituidas, antagonistas de la vasopresina.
US6953787B2 (en) * 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
PT1572215E (pt) * 2002-12-20 2009-12-09 Glaxo Group Ltd Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
EP1646623A2 (en) 2003-05-22 2006-04-19 Schering Corporation 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
CN1805938B (zh) * 2003-06-17 2010-06-16 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
AU2012200805B2 (en) * 2003-06-17 2015-01-22 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
WO2005042491A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
WO2005042490A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
EP2149562A1 (en) 2004-12-21 2010-02-03 Arena Pharmaceuticals, Inc. method of preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate
NZ589951A (en) 2004-12-23 2012-11-30 Arena Pharm Inc 5HT2C receptor modulator compositions and methods of use
CA2646044A1 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
EP2099743B1 (en) 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
JP2013539470A (ja) 2010-09-01 2013-10-24 アリーナ ファーマシューティカルズ, インコーポレイテッド ロルカセリンと光学活性な酸との塩
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태
EA201390335A1 (ru) 2010-09-01 2013-09-30 Арена Фармасьютикалз, Инк. Введение лоркасерина индивидуумам с почечной недостаточностью
KR20130101524A (ko) 2010-09-01 2013-09-13 아레나 파마슈티칼스, 인크. 5-ht2c 아고니스트의 비-흡습성 염
RU2674670C1 (ru) 2012-10-09 2018-12-12 Арена Фармасьютикалз, Инк. Способ коррекции массы тела
HU230826B1 (hu) 2014-11-19 2018-07-30 Richter Gedeon Nyrt. Eljárás benzazepin származékok előállítására

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA974989A (en) * 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
DE1934150A1 (de) * 1968-07-10 1970-01-15 Pennwalt Corp Neue 1-Alkanoyloxy-1,2,4,5-tetrahydro-3H,3-benzazepine
US4988690A (en) * 1982-06-14 1991-01-29 Hoechst-Roussel Pharmaceuticals Inc. 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
US4707483A (en) * 1985-12-20 1987-11-17 Smithkline Beckman Corporation 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof

Also Published As

Publication number Publication date
PT87068A (pt) 1988-04-01
IL85855A (en) 1993-02-21
HUT53882A (en) 1990-12-28
NO885096D0 (no) 1988-11-15
ZA882080B (en) 1989-04-26
DK165688C (da) 1993-05-24
DE3851769T2 (de) 1995-03-09
CA1321195C (en) 1993-08-10
NZ224038A (en) 1990-10-26
JPH02502723A (ja) 1990-08-30
IL85855A0 (en) 1988-09-30
MY103357A (en) 1993-06-30
NO174507C (da) 1994-05-18
KR890700577A (ko) 1989-04-25
AU619744B2 (en) 1992-02-06
NO885096L (no) 1988-11-15
WO1988007526A1 (en) 1988-10-06
HU205744B (en) 1992-06-29
AU1596488A (en) 1988-11-02
DK165688B (da) 1993-01-04
FI894566A0 (fi) 1989-09-27
EP0285919B1 (en) 1994-10-12
DE3851769D1 (de) 1994-11-17
ATE112766T1 (de) 1994-10-15
JPH0662574B2 (ja) 1994-08-17
PH27337A (en) 1993-06-08
PT87068B (pt) 1992-07-31
DK652688D0 (da) 1988-11-23
EP0357641A1 (en) 1990-03-14
NO174507B (no) 1994-02-07
FI894566A7 (fi) 1989-09-27
KR930011489B1 (ko) 1993-12-08
EP0285919A1 (en) 1988-10-12

Similar Documents

Publication Publication Date Title
MY103357A (en) Substituted benzazepines, their preparation and pharmaceutical composition containing them
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
BR0211201A (pt) Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero
CA2011346A1 (en) 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
DE2963183D1 (en) 1,4-dihydropyridine compounds, their preparation, pharmaceutical compositions containing said compounds and preparation of these compositions
ES2038172T3 (es) Procedimiento para preparar carboxamidas heterociclicas.
HU9501585D0 (en) Azoxycyanobenzene-derivatives, process for their preparation, fungicidal compositions containing them
DK160686D0 (da) Tri- og tetracycliske forbindelser
ES482285A1 (es) Procedimiento de preparacion de compuestos de benzofurano.
YU45582B (sh) Postopek za pripravo derivatov arilamina
HUT61993A (en) Process for producing new imidazolylmethylpyridyl derivatives and pharmaceutical compositions comprising same as active ingredient
GR3020509T3 (en) Alpha-methylene-2-vinyl-benzeneacetic acid derivatives, process for their preparation and their use as pesticides
GR3015512T3 (en) Thiophene derivatives, process for their preparation and pharmaceutical compositions containing them.
ES8203870A1 (es) Procedimiento para preparar difenilbutil-1-acilpiperazinas
SE9103776D0 (sv) New compounds
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
DE3067341D1 (en) Substituted 2,3-dihydrobenzofurylmethyl-cyclopropanecarboxylic acid esters, process for their preparation, process for combatting parasites, and agents therefor
ZA875727B (en) 1,4-dihydropyridine derivatives,the process for preparing them and the pharmaceutical compositions which contain them
SE8801945D0 (sv) New 5-methoxy alkyl ammonium tetrahydrofurans and tetrahydrothiophenes
ES8900162A1 (es) Procedimiento para la obtencion de 3-acilaminobenzisotiazol-s,s-dioxidos
HUT58471A (en) Herbicidal composition comprising (sulfamidosulfonyl)-urea derivatives as active ingredient and process for producing the active ingredients
HUT57746A (en) Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same
SE8701524L (sv) Nya sulfonamider och deras framstaellningsfoerfarande
HUT53890A (en) Fungicides comprising o-(1,2,4-triazol-1-yl)-o-phenylacetate derivatives as active ingredient and process for producing the active ingredients